Literature DB >> 2261326

End-to-side aortoprosthetic anastomoses: long-term computed tomography assessment.

A Mikati1, P Marache, A Watel, H Warembourg, J P Roux, D Noblet, G Soots.   

Abstract

Fifty-two asymptomatic patients underwent routine computed tomographic evaluation of aortobifemoral bypass grafts implanted end-to-side on the aorta five to 10 years after operation. Anteroposterior diameters were measured at the level of the stem and the limbs of the graft, the aortoprosthetic anastomosis, and the infraanastomotic aorta. The stems of the prostheses were found to be dilated between 30 and 110% (mean 58%) of initial values. The limbs of the graft were dilated between 15 and 150% of initial values, the mean being 52%. The anteroposterior diameter of the aortoprosthetic anastomosis measured between 27 and 48 mm with a mean of 32 mm. Eight patients (15%) had an anastomotic false aneurysm. The aorta distal to the prosthetic anastomosis was completely occluded in 48 cases (92%). A mural thrombus was encountered at the level of the aortoprosthetic anastomosis in 21 (40%) patients. These findings raise questions as to the possible role of side-to-end aortoprosthetic anastomoses in the genesis of anastomotic dilatations, false aneurysms, intraprosthetic thrombosis, and thrombosis of the branches of aortofemoral bifurcation prosthetic grafts.

Entities:  

Mesh:

Year:  1990        PMID: 2261326     DOI: 10.1016/S0890-5096(06)60844-3

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  2 in total

1.  Endovascular treatment of a noninfected anastomotic juxtarenal aortic aneurysm.

Authors:  G Melissano; C Di Mario; Y Tshomba; E Civilini; G Gimelli; R Nicoletti; A Del Maschio; A Colombo; R Chiesa
Journal:  Tex Heart Inst J       Date:  2000

2.  Uninfected para-anastomotic aneurysms after infrarenal aortic grafting.

Authors:  Paolo Bianchi; Giovanni Nano; Francesco Cusmai; Fabio Ramponi; Silvia Stegher; Daniela Dell'Aglio; Giovanni Malacrida; Domenico G Tealdi
Journal:  Yonsei Med J       Date:  2009-04-30       Impact factor: 2.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.